Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.

Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page
- Check4 days agoChange DetectedA new page revision (v3.5.4) was added to replace the previous revision (v3.5.3). This indicates an updated version of the study details page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s displayed revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a site release/version change without altering the underlying study details.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.0 has been added, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision tag on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded an optional tag 'Gastric cancer' and a new 'Genetic and Rare Diseases Information Center' resource under Resources. These changes provide additional context but do not modify the trial details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.